Contributing to the evolution of SCIENCE

by: Dr. Robert L. Bard

I welcome all innovation developers who support the healing arts community. My specialized work pursues the advancement of MEDICAL RESEARCH with NON-INVASIVE SURROGATE ENDPOINTS with the hopes of contributing my talents to your current and future projects. With over 45 years in the field of advanced diagnostic sciences, I have dedicated my life's work to the clinical examination and targeted analyses of all subdermal disorders using the latest quantifiable digital imaging innovations. I have established an entire foundation dedicated to Medical Research committed originally to the exploratory studies of all cancer treatment proctocols. Alongside this, I have also been most active in collaboration with some of the top treatment strategists, health centers, clinical labs, experimental/alternative treatment professionals and medical device manufacturers. I have earned a reputation for my investigative approach within various examination paradigms including progress monitoring and surveillance.

I have the greatest interest in supporting all entities committed to contributing technical innovations and new advancements in treatment solutions to our medical community. By this, my foundation team and I wish to build a partnership to conduct clinical research projects where you may find our validation capabilities to be a priceless benefit your overall objectives.

Most research sponsors and medical developers' testing and validation needs often fall into one of a number of common task categories- all within the objectives of public health, safety and healthcare support. Upon review of the various research concepts mentioned in this presentation, we look forward to learning about your project with the hopes of supporting your needs and objectives.


Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people. Often a clinical trial is used to learn if a new treatment is more effective and/or has less harmful side effects than the standard treatment.

Other clinical trials test ways to find a disease early, sometimes before there are symptoms. Still others test ways to prevent a health problem. A clinical trial may also look at how to make life better for people living with a life-threatening disease or a chronic health problem. Clinical trials sometimes study the role of caregivers or support groups.

Medical research protects the relationship between the developer of clinical solutions and the patient community of its treatment or performance claims. Tests performed by an unbiased agencies like the AngioFoundation ensures the acquisition of untainted, unbiased data from a dedicated review campaign.
Medical device manufacturers/inventors, drug developers, producers of additives and supplements or any entities that create materials that are accessory to healthcare treatments. Also, upgrades and modifications to these products will require further PROOFING or VALIDATION under similar testing.
Producers earn the benefits of public confidence from the information harvested in Clinical Trials. To establish performance standards (let it be through regulatory compliance testing or internal quality assurance reviews) is a significant asset for any product being introduced into the market.

Use of Advanced Digital (3D/4D) Doppler Sonographic Imaging technology to MONITOR, TRACK, SCREEN and IDENTIFY all treatment responses, successes & efficacy. The AngioFoundation team is experienced with designing a comprehensive Clinical Trial format for all medical protocol developers. The Doppler system is the safest repeat scanning solution for performance monitoring and staging use (no radiation) allowing the tester to accurately achieve and generate a comparative view of Before-After studies. Working with all test patients within this proven and stable paradigm can be incorporated with other current imaging technologies such as MRI, CT etc. Acquire useful data from concurrent patient testing programs such as: duration of desired response, resistance analysis, dosage-effect ratios, statistics assessment, secondary physiological responses and more.

Dr. Bard has supported countless projects, many of them pertaining to the achievement of regulatory standards. From medical device companies, clinical labs and pharma products, our resarch programs have helped to achieve proper certifications and compliance. By this, we perform a complete and highly detailed VALIDATION analysis of the product in question- reviewing all available benefits, a comprehensive assessment of their intended usage and short and long term effects- detailed within your compliance applications, supportive documentation and ansilary reporting.

As a researcher, Dr. Bard welcomes collaborating with all developers under varying types of research paradigms. To determine a conclusive study within sensible variable scenarios or to help identify and confirm the developer's intended results of their product design, we can offer a wide array of clincal trial design angles including: CASE-CONTROL STUDIES, CASE REPORTING, META ANALYSES, COST-BENEFIT ANALYSIS, DOUBLE BLIND STUDIES, EMPIRICAL RESEARCH just to name a few.
Within a closed testing program of 45-50 patients, a comparative review of pre and post treatment allows the developer a clear view of its efficacy and performance. Through the use of various imaging technologies and the experienced assessment strategies of our diagnosticians, we are able to provide the desired data which leads the devleoper to identify quality standards as they apply to the inevitable end user en masse.

Research & Educational PROGRAMS
The AngioFoundation has been recognized worldwide by official medical organizations and peer reviews for its work in FIVE MAIN focal topics and class divisions. We continually maintain and update research works in these categories to support the advancement of these disciplines as part of The AngioFoundation's commitment to the scientific community. Below is a selected examples of medical reseearch projects:

• Efficacy of Injected Hyaluronidase Filler Reduction Dept Dermatology Mt Sinai
Marmur E  HS#14-00291 | Icahn School of Medicine 2015

• Photoacoustic and Optical Imaging
Bard R, Krueger L, Rasmussen S Rockefeller University 2013-2014

• Doppler Evaluation of Radiation Treatment Response
Bard R, Kaplan A 2013-2014 NY Medical College

• 3D Doppler Sonography of Malignant Melanoma 
Bard R, Lefkovitz A In conjunction with Mt Sinai Medical Center New York, NY 2013-2014

• 3D Imaging of Psoriasis
Bard R, Lebwohl M, Wortsman X In conjunction with Mt. Sinai Med Ctr New York, NY 2012

• Doppler Vessel Density in Melanoma
Morton D, Bard R in conjunction with John Wayne Cancer Institute Santa Monica 2009-2010

•  Prostatic Volume Reduction Implementing Radiotherapy Treatment Application
Rotman M, Bard R.  Applications in Prostate Cancer Patients 2006-2008
In conjunction with Downstate Medical Center Brooklyn, NY

• Ultrasonography of the Spine in Rheumatoid Arthritis
Smith M, Bard R | Dept Rheumatology St. Vincents Hospital New York 2000-2001
in conjunction with New York Medical College Valhalla, NY

• Ultrasound Evaluation of the Patient with Rheumatoid Arthritis
Smith M, Prashad R, Bard R et al | Dept Rheumatology St. Vincents Hospital New York 1997-1998 in conjunction with New York Medical College Valhalla, NY

Click HERE at pgs 19-21 for a complete list of AngioFoundation Research Projects


A significant asset to the medical community is publishing our research studies for complete academic access through medical journals and through full-text distribution with Springer Publishing Inc. Publishing all findings of our research reports maintains the tradition of supporting the growth of current and future generations of clinicians and for the expansion of the vast majority of relevant audiences who benefit from our discoveries. Under the authorship of Dr. Robert Bard, we have amassed over 18 combined years of research and generated countless articles, over 22 scientific textbooks with various topics and hundreds of presentations to the medical community worldwide.

(see Pg. 6-19 books published & international presentations)




Research Support and Fundraising EVENTS

May 10, 2018- NYC; The LOTOS CLUB hosted the 2018 speaker series with Dr. Robert Bard's opening presentation on Early Detection & Prevention by NYCRA (New York Cancer Resource Alliance) and endorsed Dr. Bard to launch this theme because of his expanded knowledge in today's modern diagnostic technologies and non-invasive applications including the 4D Doppler ultrasound technology - much of which has been driven by European medical influence for the cancer treatment community. Dr. Bard is an internationally recognized leading expert in the use of this process for the screening, scanning and pre/post procedural monitoring of Breast, Prostate & Skin Cancers. He is also known for his public mission to replace surgical analysis of tumors with his coined "digital biopsies". Dr. Bard gave the standing-room only audience at the LOTOS CLUB an astounding look at the effectiveness of his imaging process to the surgical chain. He shared images of actual patient cases including the study of blood flow in tumors, behaviors of cysts, foreign bodies in trauma cases, fracture analysis and proven ways that cancers can be safely detected, studied and even treated with the use of non-surgical means. The high accuracy of 3D-4D Histogram analysis allows cancer treatment to be implemented without invasive biopsies that may spread tumor cells. (full article)



Research results in APPLIED SCIENCE


In my extensive career as the medical director of an advanced imaging diagnostics practice, I have provided great assistance to many surgeons with my work using advanced Doppler Scanning of Tumors and Cosmetic Disorders. I have uncovered countless dermal and subcutaneous issues that would have otherwise gone undetected with less effective technologies, leading to potential complications in the surgical procedure and patient recovery. The advancement in this innovation empowers upcoming surgical procedures with remarkable confidence of a safer end result. Where biopsies are becoming a thing of the past, our non-invasive 4D Digital imaging replaces weeks of lab work and radiologic tests and often provides more useful information. (see complete article)

DIGITAL BIOPSY CASES: WHAT ARE YOU ABOUT TO BIOPSY? WHAT HAPPENS AFTER THE NEEDLE INSERTS? Here we have 2 subdermal masses which are non tender and firm with no history of trauma. Case A: The oval mass (dark echoes=suspicious) with irregular vessels (red) was referred as a probable cyst or lipoma. The tumor is highly vascular and connected from the aorta by way of the subclavian feeding artery. Liposuction could result in massive hemorrhage and spread of tumor cells into the circulation.


Case B: The ovoid white region (bright echoes=benign) is ossified as confirmed by the CT scan of the coccyx. The sonogram allows you to reassure the patient it is NOT CANCER. It prompts one to avoid a standard needle that could bend, crack or dislodge into the soft tissues requiring further exploration to locate/retrieve the broken metal fragment.

Copyright (C) 2019- The Biofoundation for Angiogenesis Research and Development- a 501C3. All Rights Reserved. (